Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database
Zhenpo Zhang, Jingping Zheng, Yankun Liang, Qimin Wu, Chufeng Ding, Lin Ma, Ling Su
Springer Nature ·
2025-05-09
· DOI 10.1186/s12885-025-14227-4
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Zhenpo Zhang, Jingping Zheng, Yankun Liang, Qimin Wu, Chufeng Ding, Lin Ma et al. Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database. // BMC Cancer. – 2025. – DOI: 10.1186/s12885-025-14227-4. – URL: https://doi.org/10.1186/s12885-025-14227-4
Zhenpo Zhang, Jingping Zheng, Yankun Liang, Qimin Wu, Chufeng Ding, Lin Ma, & Ling Su (2025). Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database. BMC Cancer. https://doi.org/10.1186/s12885-025-14227-4
Zhenpo Zhang, et al. “Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database.” BMC Cancer, 2025. doi:10.1186/s12885-025-14227-4.
@article{Zhang2025,
title = {Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database},
author = {Zhang, Zhenpo and Zheng, Jingping and Liang, Yankun and Wu, Qimin and Ding, Chufeng and Ma, Lin and Su, Ling},
journal = {BMC Cancer},
year = {2025},
doi = {10.1186/s12885-025-14227-4},
url = {https://doi.org/10.1186/s12885-025-14227-4}
}